BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32102485)

  • 1. MYC's Fine Line Between B Cell Development and Malignancy.
    de Barrios O; Meler A; Parra M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32102485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.
    Barneda-Zahonero B; Collazo O; Azagra A; Fernández-Duran I; Serra-Musach J; Islam AB; Vega-García N; Malatesta R; Camós M; Gómez A; Román-González L; Vidal A; López-Bigas N; Villanueva A; Esteller M; Parra M
    Cell Death Dis; 2015 Feb; 6(2):e1635. PubMed ID: 25675295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
    Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
    Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.
    Calado DP; Sasaki Y; Godinho SA; Pellerin A; Köchert K; Sleckman BP; de Alborán IM; Janz M; Rodig S; Rajewsky K
    Nat Immunol; 2012 Nov; 13(11):1092-100. PubMed ID: 23001146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
    Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
    Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.
    Sheikh BN; Lee SC; El-Saafin F; Vanyai HK; Hu Y; Pang SH; Grabow S; Strasser A; Nutt SL; Alexander WS; Smyth GK; Voss AK; Thomas T
    Blood; 2015 Mar; 125(12):1910-21. PubMed ID: 25605372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements.
    Högstrand K; Lindvall JM; Sundblad A; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):454-461. PubMed ID: 30664244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
    Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D
    Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
    Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
    Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal location targets different MYC family gene members for oncogenic translocations.
    Gostissa M; Ranganath S; Bianco JM; Alt FW
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
    Farrell AS; Pelz C; Wang X; Daniel CJ; Wang Z; Su Y; Janghorban M; Zhang X; Morgan C; Impey S; Sears RC
    Mol Cell Biol; 2013 Aug; 33(15):2930-49. PubMed ID: 23716601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
    Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
    Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC, Metabolism, and Cancer.
    Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
    Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.